The global generative AI in healthcare market, valued at $1.84 billion in 2024, is projected to grow at a 31.4% CAGR to reach $21.64 billion by 2034. Growth is fueled by solutions for medical imaging, diagnostics, drug discovery, and administrative automation, addressing physician burnout and improving clinical outcomes. North America leads the market due to advanced infrastructure and investments, while cloud-based deployments and large language models dominate technology use. Challenges include regulatory hurdles, data privacy, and integration with legacy systems, but opportunities exist in specialized AI models and emerging markets.
Anthropic CEO Dario Amodei has called for the AI industry to slow down development due to safety risks, including potential uncontrollable AI behaviors. Despite this warning, major companies like NVIDIA, Microsoft, Alphabet, and Amazon continue heavy...
The iShares Core Dividend Growth ETF (DGRO) has underperformed compared to SCHD and the S&P 500, rising about 10.4% since March versus 12.1% and 13.6% respectively. Its diluted large-cap exposure and low yield of around 1.89% make it less attractive,...
Investors are rotating capital into frontier tech stocks such as SpaceX, Anthropic, and OpenAI, anticipating their upcoming IPOs and signaling a shift from legacy tech giants. The FAB 10 and MANGOS baskets highlight this trend, with SpaceX's $75 bill...
Fidelity's Yield Enhanced Equity ETF (FYEE) has outperformed the popular JPMorgan Equity Premium Income ETF (JEPI) in 2026 by delivering a higher total return of 10.44% year-to-date compared to JEPI's 3.85%, while providing nearly the same cash incom...
SanDisk's stock surged 2,107% over the past year, driven by explosive growth in AI-related data storage demand and strong financial results, including a 371.6% revenue increase in fiscal Q4 2026. This remarkable performance has shifted the market lan...
